who made retatrutide 10mg Retatrutide 24 mg & 40

*Correspondence: Hardyanto Soebono, [email protected] This article was submitted to Human and Medical Genomics, a section of the journal Frontiers in Genetics Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Peptide therapy is not inherently dangerous, but unsupervised use carries real risks

More serious risks disclosed by HumeCare include acute pancreatitis, acute gallbladder disease, low blood sugar (particularly relevant for anyone also taking insulin or sulfonylureas), acute kidney injury related to dehydration, and serious allergic reactions

Those numbers sound terrifying